We puri®ed a novel actin ®lament (F-actin)-binding protein from the soluble fraction of Saccharomyces cerevisiae by successive column chromatographies by use of the 125 I-labeled F-actin blot overlay method. The puri®ed protein showed a minimum M r of about 140 kDa on SDS-polyacrylamide gel electrophoresis and we named it ABP140. A search with the partial amino acid sequences of ABP140 against the Saccharomyces Genome Database revealed that the open reading frame of the ABP140 gene (ABP140) corresponded to YOR239W fused with YOR240W by the +1 translational frame shift. The encoded protein consisted of 628 amino acids with a calculated M r of 71,484. The recombinant protein interacted with F-actin and showed the activity to crosslink F-actin into a bundle. Indirect immuno¯uorescence study demonstrated that ABP140 was colocalized with both cortical actin patches and cytoplasmic actin cables in intact cells. However, elimination of ABP140 by gene disruption did not show a deleterious eect on cell growth or aect the organization of F-actin. These results indicate that ABP140 is not required for cell growth but may be involved in the reorganization of F-actin in the budding yeast.
Introduction
Reorganization of the actin cytoskeleton is essential for cell shape change, cell motility, and regulation of cellto-cell and cell-to-matrix adhesion (Pollard and Cooper, 1986; Gumbiner, 1996; Lauenburger and Horwitz, 1996) . Many actin-binding proteins and many factors which regulate reorganization of the actin cytoskeleton have been identi®ed (Pollard and Cooper, 1986; Vandekerckhove, 1990; Gips et al., 1994) . Recent studies have clari®ed that the Rho family members, which belong to the Ras-related small G protein superfamily, are a novel type of the factors which regulate cell shape change, cell motility, and cell-to-cell adhesion through reorganization of the actin cytoskeleton (Takaishi et al., 1997 ; for reviews, see Hall, 1994; . Many upstream regulators and downstream target molecules have been isolated, but the modes of activation and action of the Rho family members have not been fully understood.
In the yeast Saccharomyces cerevisiae, the actin cytoskeleton is involved in the establishment and maintenance of polarized secretion and cell growth (Madden et al., 1992; Welch et al., 1994) . Yeast possesses the homologs of mammalian Rho family, including RHO1, RHO2 (Madaule et al., 1987) , RHO3, and RHO4 (Matsui and Toh-e, 1992) . RHO1 is a counterpart of the mammalian RhoA gene and we have shown that the rho1 mutants are de®cient in the budding process . We have recently identi®ed the downstream targets of Rho1p to be Pkc1p, 1,3-b-glucan synthase, and Bni1p (Nonaka et al., 1995; DrgonovaÂ et al., 1996; Kohno et al., 1996) . Pkc1p is a homolog of mammalian protein kinase C and regulates cell wall integrity through activation of the MAP kinase cascade (Levin and Errede, 1995) . Glucan synthase is involved in cell wall synthesis (Shematek and Cabib, 1980) . Bni1p is known to be implicated in cytokinesis and establishment of cell polarity (Jansen et al., 1996; Zahner et al., 1996) . We have moreover found that Bni1p directly interacts with pro®lin, an actin monomer-binding protein, which accelerates the polymerization of actin (Imamura et al., 1997) . It is likely that Rho1p regulates the reorganization of the actin cytoskeleton through the Bni1p-pro®lin system in the budding yeast.
In yeast, a single essential gene (ACT1) encodes the sole source of`conventional' actin (Gallwitz and Sures, 1980; Ng and Abelson, 1980) . Yeast actin is about 90% identical to rabbit muscle actin at the amino acid sequence level, and the biochemical properties of yeast actin are similar to those of rabbit muscle actin. The product of this single gene in yeast assembles into two dierent structures: cortical patches and cytoplasmic cables (Adams and Pringle, 1984) . The distribution of both patches and cables changes dramatically over time during the cell cycle (Kilmartin and Adams, 1984) . During vegetative growth, an asymmetric distribution of these structures is apparent, with the cortical patches localizing to sites of cell surface growth and the cables often oriented toward these regions. Following entry into the cell cycle from G0 or after G1 phase, when the cortical patches are delocalized over the entire cell surface, the bud starts to grow from the cells. As the bud develops, most of the patches appear in the growing tip of the daughter cell, with the cables appearing to be oriented along the long axis of the mother cell. As the daughter cell matures, the patches are localized to the septum, with the cables appearing to radiate from this region. These dynamic changes of the actin structures require the actin-binding proteins which interact directly with actin and regulate the reorganization of the actin cytoskeleton (Madden et al., 1992; Welch et al., 1994) . Several genes encoding actin-binding proteins have been identi®ed and characterized in yeast: these include MYO1 (myosin I), MYO2 (myosin II), COF1 (co®lin), PFY1 (pro®lin), and TPM1 (tropomyosin) (Madden et al., 1992; Welch et al., 1994) . Genetic analyses have demonstrated that the activities of these actin-binding proteins are important for proper actin function in yeast. Specifically, mutations in the genes that encode actin-binding proteins often result in phenotypes similar to those of actin mutations.
We have recently found that the Rho subfamily members regulate the interaction of ERM (ezrin/ radixin/moesin) with the plasma membrane and thereby regulate the reorganization of the actin cytoskeleton in mammal (Takaishi et al., 1995; Hirao et al., 1996) . In general, actin ®laments are associated with the plasma membrane through peripheral membrane proteins which directly interact with actin ®lament (F-actin), such as ERM, catenin, and vinculin (Luna and Hitt, 1992; Tsukita et al., 1993; Cowin and Burke, 1996) . However, this type of F-actin-binding protein has not been identi®ed in yeast. Moreover, a computer homology search against Saccharomyces Genome Database has revealed that there is no counterpart of these F-actin-binding proteins in the budding yeast. We have therefore attempted here to isolate F-actin-binding proteins which may serve as a linker of F-actin to the plasma membrane. We have isolated a novel actin-binding protein from Saccharomyces cerevisiae. We have named this protein ABP140, because it has a minimum M r of about 140 kDa on SDS-polyacrylamide gel electrophoresis (PAGE).
Results

Puri®cation of ABP140 from the yeast cytosol fraction
To identify novel F-actin-binding proteins from the budding yeast, we attempted to detect F-actin-binding proteins by use of the 125 I-labeled F-actin blot overlay method. The homogenate was prepared from a yeast strain BJ5457, which contained less proteases, and subjected to SDS ± PAGE, followed by the 125 I-labeled F-actin blot overlay (Figure 1 ). An F-actin-binding protein band with a M r of about 140 kDa was detected. This F-actin-binding protein band was detected in the cytosol fraction, whereas no F-actinbinding protein was detected in the membrane fraction. This protein was named ABP140.
ABP140 was highly puri®ed from the cytosol fraction by successive column chromatographies, including Mono S HR 16/10, hydroxyapatite, and TSKgel phenyl-5PW RP column chromatographies. In each column chromatography, the 
Nucleotide and amino acid sequences of ABP140
The TSKgel phenyl-5PW RP sample of ABP140 (30 mg of protein) was subjected to SDS ± PAGE. The protein band corresponding to ABP140 was cut out from the gel and digested with lysyl endopeptidase, and the digested peptides were separated by TSKgel ODS-80Ts reverse phase high-performance liquid column chromatography. Over 20 peptides were observed, and the amino acid sequences of the ®ve peptides (peptide-10, -14, -15, -18, and -19) were determined. Furthermore, the N-terminal amino acid sequence of ABP140 was determined. A search with these amino acid sequences against the Saccharomyces Genome Database revealed that the N-terminal peptide, peptide-14, and peptide-15 were included in the amino acid sequence of a putative open reading frame, YOR239w, in chromosome XV. On the contrary, peptide-10 and peptide-19 were included in YOR240w, which is the next open reading frame downstream of YOR239w. The amino acid sequence of peptide-18 consisted of the parts of the C-terminal region of YOR239w and the N-terminal region of YOR240w, suggesting that YOR239w and YOR240w constitute the ABP140 gene (ABP140). We determined DNA sequences encompassing the Cterminal region of YOR239w and the N-terminal region of YOR240w and con®rmed the DNA sequence reported in the Saccharomyces Genome Database to be correct. A +1 translational frame shift has been reported in seven nucleotides sequence of the TYB gene of yeast Ty retrotransposons (Belcourt and Farabaugh, 1990) . Surprisingly, YOR239w pos- Ilabeled F-actin blot overlay method. The homogenate, the cytosol fraction, and the membrane fraction of yeast cells (BJ5457) (50 mg each of protein) were subjected to SDS ± PAGE, followed by the 125 I-labeled F-actin blot overlay. The protein markers used were myosin (Mr=205 000), b-galactosidase (Mr=120 000), bovine serum albumin (Mr=85 000), and ovalbumin (Mr=47 000). Lane 1, the homogenate; lane 2, the cytosol fraction; lane 3, the membrane fraction sessed exactly the same sequence, CTTAGGC, in which CTT corresponded to the codon 277 for leucine. If the +1 translational frame shift would occur at the codon 277, YOR239W would be fused with YOR240W and the amino acid sequence of peptide-18 would perfectly match the predicted amino acid sequence of the resulting open reading frame. We concluded that this amino acid sequence is most probable for ABP140 (Figure 3 ). The encoded protein consisted of 628 amino acids and showed a calculated M r of 71 484, which was much lower than the observed M r of about 140 kDa on SDS ± PAGE. This discrepancy might be due to an abnormal tertiary structure of ABP140 or a dimer formation of ABP140 which is resistant to a reducing reagent.
A computer homology search revealed that the deduced amino acid sequence of expressed sequence tag from human (accession number R63104) is 54% identical to a limited region (amino acid positions 529 ± 615) of the deduced amino acid sequence of ABP140, suggesting that there may be a counterpart of ABP140 in mammal.
Recombinant ABP140
To con®rm whether the DNA fragment encoding fulllength ABP140, we isolated this DNA fragment from the total yeast genome by PCR, constructed the expression vector with this DNA fragment, and expressed the HA-tagged protein in the yeast cells (BJ5457). The cytosol fraction was prepared from the HA-tagged ABP140-overexpressing cells and subjected to SDS ± PAGE, followed by the 125 I-labeled F-actin blot overlay. An F-actin-binding protein band was detected in the cytosol fraction (1 mg of protein), although native ABP140 was not detected in the same amount of the cytosol fraction prepared from the wildtype cells ( Figure 4A ). Recombinant HA-tagged ABP140 showed the mobility similar to that of native ABP140 on SDS ± PAGE. Therefore, we concluded that this DNA fragment encoded full-length ABP140.
Recombinant HA-tagged ABP140 was puri®ed from the cytosol fraction of the yeast cells overexpressing this protein by successive column chromatographies, including Mono S HR10/10, hydroxyapatite, and Superdex 200 HR10/30 column chromatographies. On the ®nal Superdex 200 HR10/30 column chromatography, ABP140 appeared in a single peak at a position with a M r of about 240 kDa (data not shown). Recombinant ABP140 was highly puri®ed as estimated by SDS ± PAGE and showed the 125 I-labeled F-actin-binding activity ( Figure 4B ). Therefore, this recombinant protein was used to study the properties of ABP140 as described.
Properties of ABP140
In addition to the 125 I-labeled F-actin blot overlay, the binding of ABP140 to F-actin was examined by I-labeled F-actin blot overlay of the phenyl-5PW column chromatography. An aliquot (5 ml) of each fraction was subjected to SDS ± PAGE, followed by the 125 I-labeled F-actin blot overlay. Another aliquot (80 ml) of each fraction was subjected to SDS ± PAGE, followed by protein staining with Coomassie brilliant blue. The protein markers used were the same as those used in Figure 1 . Arrows indicate the positions of ABP140 cosedimentation with F-actin. When recombinant ABP140 was incubated with F-actin followed by ultracentrifugation, ABP140 was recovered with Factin in the pellet ( Figure 5 ). ABP140 bound to F-actin at a molar ratio of one ABP140 molecule to about 30 actin molecules (data not shown). It was next examined by a competition experiment whether ABP140 bound along the sides of F-actin or its ends. The binding of 125 I-labeled F-actin to recombinant ABP140 was inhibited by an excessive amount of myosin subfragment 1, a well-characterized protein which binds along the sides of F-actin Schroder et al., 1993) (data not shown). This result indicated that ABP140 bound along the sides of F-actin.
The eect of recombinant ABP140 on the viscosity of F-actin was next examined by the falling-ball method. This eect was compared to that of aactinin, a well-characterized protein which shows the F-actin-cross-linking activity (Burridge and Feramisco, 1981) . ABP140 increased the viscosity in time-and dose-dependent manners, but the viscosity became maximally about ®vefold ( Figure 6A ). In contrast, aactinin increased the viscosity, so that the steel ball became lodged in the gel (data not shown). These Figure 3 Nucleotide and deduced amino acid sequences of ABP140. The amino acid sequences determined from the TSKgel phenyl-5PW RP sample of ABP140 are indicated by solid underlines; numbers below these sequences correspond to the peptide numbers. Nucleotide sequence is referred to the data from the Saccharomyces Genome Database. Nucleotide sequences used for designing PCR primers are indicated by dashed underlines. The possible slip site for the +1 translational frame shift is indicated by bold letters results suggest that ABP140 has weak F-actin-crosslinking activity. This activity of ABP140 was con®rmed by transmission electron microscopy of negatively stained specimens. ABP140 caused F-actin to associate into thin bundles ( Figure 6B ), under the conditions where a-actinin caused F-actin to associate into thick bundles (data not shown). We ®nally examined the eect of recombinant ABP140 on actin polymerization using pyrene-conjugated actin. Pyreneconjugated actin is known to increase its¯uorescent intensity with actin polymerization . ABP140 did not aect actin polymerization (Figure 7) .
Localization of ABP140 in yeast cells
To examine the function of ABP140, we established the ABP140-null mutant yeast cells by gene disruption. The ABP140-null mutant cells were normal in phenotypes so far tested, including growth at 248C or at 378C, mating potency with the wild-type cells of an opposite mating type, and budding pattern (data not shown). To assess the localization of ABP140, the ABP140-null mutant cells expressing HA-tagged ABP140 were next prepared. These mutant cells were also morphologically indistinguishable from the wildtype cells and used for the indirect immuno¯uorescence microscopy with the anti-HA monoclonal antibody (mAb). The same preparation was doubly stained with rhodamine-phalloidin to visualize F-actin. The staining with the anti-HA mAb was observed in both cortical actin patches (Figure 8 ) and actin cables (data not shown).
Discussion
We have puri®ed here a novel F-actin-binding protein from the cytosol fraction of S. cerevisiae and characterized it. Because this novel F-actin-binding protein shows a minimum M r of about 140 kDa on SDS ± PAGE, we have named it ABP140. Many actinbinding proteins in yeast show amino acid sequences similar to those of mammalian proteins. However, ABP140 does not have any homologous regions to any known actin-binding proteins in mammal or yeast. Our biochemical study has revealed that ABP140 directly interacts with F-actin and binds Mr (kDa) Figure 5 Cosedimentation of ABP140 with F-actin. Recombinant HA-tagged ABP140 was incubated in the presence or absence of F-actin, and the mixture was then centrifuged. The supernatant and the precipitate were subjected to SDS ± PAGE (8 ± 13% polyacrylamide gel), followed by protein staining with Coomassie brilliant blue. Lane 1, the supernatant; lane 2, the precipitate A novel F-actin-binding protein T Asakura et al along the sides of F-actin. Moreover, ABP140 has weak F-actin-cross-linking activity. Most actin-binding proteins in mammal and yeast belong to one of several families: monomer-binding proteins, capping proteins, severing proteins, and cross-linking proteins. According to this classi®cation, ABP140 belongs to the family of cross-linking proteins. Most cross-linking proteins share a common actin-binding domain, and this domain is combined with spacer domains consisting of a variable number of repeated a-helical and b-sheet motifs, which generate proteins that dier in their ability to form actin bundles or networks (Matsudaira, 1991) . However, structural analysis has revealed that ABP140 does not have such a common actin-binding domain with spacer domains. Moreover, although the stoichiometry of the binding of most cross-linking proteins to actin molecules is 1:4 ± 1:6, that of ABP140 is about 1:30. Consistently, ABP140 has weaker activities to increase the viscosity of Factin and to associate F-actin into bundles than aactinin. ABP140 may belong to a family of crosslinking proteins dierent from those thus far reported. Actin-binding proteins are located at either cortical actin patches or cytoplasmic actin cables, or both in yeast. Our immuno¯uorescence study has revealed that ABP140 is colocalized with both the F-actin structures. This result has provided additional evidence that ABP140 is an F-actin-binding protein. However, the ABP140-null mutant cells show no defects in these two structures or morphology of the cells. Mutations in the genes that encode actin-binding proteins often aect the organization of the actin cytoskeleton. For example, deletion of CAP1, encoding a homolog of mammalian capping protein, CapZ, causes aberrant cell morphology, disorganization of cortical actin structures, and partial disappearance of cytoplasmic cables (Amatruda et al., 1992) . In contrast, in some cases, only speci®c combinations of mutations of two or more actin-binding proteins aect the reorganization of the actin cytoskeleton. For example, ABP1, encoding one of the actin-binding proteins, has been reported to show no eect on the organization of F-actin through its elimination by gene disruption (Drubin et al., 1988; Adams et al., 1989) . By the synthetic lethal screening of ABP1, mutations that create a requirement for ABP1 have been identi®ed in three genes; SAC6, SLA1, and SLA2 (Adams et al., 1989; Holtzman et al., 1993) . One of these genes, SAC6, encodes the yeast counterpart of mammalian ®mbrin, an F-actin cross-linking protein (Adams et al., 1989; Holtzman et al., 1993) . Therefore, our results together with these earlier observations suggest that there might be another gene product(s) that cooperates with ABP140 in regulating the reorganization of the actin cytoskeleton. Genetic screening to identify such proteins is necessary to clarify the exact function of ABP140.
Rho1p regulates the reorganization of the actin cytoskeleton at least through the Bni1p-pro®lin system in the budding yeast (Kohno et al., 1996; Imamura et al., 1997) . We have examined a possible interaction of ABP140 with Rho1p, Bni1p, and pro®lin by use of the yeast two-hybrid system. However, ABP140 does not interact with these proteins (data not shown). Therefore, it is unlikely that ABP140 is involved in at least the Rho1p-regulated reorganization of the actin cytoskeleton. However, it is possible that the Rho family members other than Rho1p and their related proteins interact with ABP140. Further studies are necessary for our understanding of the functions and modes of action of the Rho family members and ABP140 in the budding yeast.
Materials and methods
Growth conditions for yeast cells
For puri®cation of ABP140, a Saccharomyces cerevisiae strain (BJ5457, aUra3-52 trp1 lys2-801 leu2D1 his3D200 pep4: :HIS3 prb1D1.6R can1) was cultured in YPDAU medium (1% Bacto-yeast extract, 2% Bacto-peptone, 2% glucose, 0.04% adenine and 0.02% uracil) with continuous agitation at 308C unti late logarithmic phase, and cells were harvested and stored at 7808C until use.
Assay for
125 I-labeled F-actin blot overlay 125 I-Labeled F-actin blot overlay was done as described (Chia et al., 1991; Pestonjamasp et al., 1995) . Actin monomer (G-actin) was prepared from rabbit muscle as described (Pardee and Spudich, 1982) . Puri®ed G-actin was labeled with 125 I-Bolton Hunter reagent (Amersham). 125 ILabeled G-actin (1 mg/ml, average speci®c activity of 63.3 mCi/mg) was polymerized with 18 mg/ml of gelsolin (Sigma) (molar ratio, 100:1) by incubation for 10 min at 48C in a solution containing 20 mM piperazine-N,N'-bis(2-ethanesulfonic acid)/NaOH at pH 7.0, 50 mM KCl, and 2 mM MgCl 2 . Phalloidin was then added to give a ®nal concentration of 40 mM. The mixture was then incubated for another 15 min at room temperature and stored at 48C as 125 I-labeled F-actin. The sample to be tested was subjected to SDS ± PAGE and transferred to a nitrocellulose membrane sheet (0.45 mm pore size, Schleicher & Schuell). The sheet was blocked in TBST (20 mM Tris/HCl at pH 7.5 containing 140 mM NaCl and 0.05% (w/v) Tween 20) containing 5% (w/v) defatted powder milk. The sheet was then incubated for 1 h at room temperature with 10 mg/ml of 125 I-labeled F-actin in TBST containing 5% defatted powder milk and 5 mM phalloidin. After the incubation, the sheet was washed three times (1 min/wash) with TBST, followed by autoradiography using an image analyser (Fujix BAS2000).
For competition experiments,
125
I-labeled F-actin was prepared as described above except that the concentration of gelsolin was reduced to 7.2 mg/ml (molar ratio, 250:1). Twenty mg/ml of 125 I-labeled F-actin was incubated for 30 min at room temperature with 0.42 mg/ml of myosin subfragment 1 (Sigma) in a solution containing 20 mM piperazine-N,N'-bis(2-ethanesulfonic acid)/NaOH at pH 7.0, 58 mM KCl, 2 mM MgCl 2 , 130 mM CaCl 2 and 0.8 mM phalloidin in the presence or absence of 2 mM ATP. After the incubation, the mixture was diluted with an equal volume of TBST containing 10% defatted powder milk, and the resulting mixture was added to the blot membrane sheet, followed by incubation for 1 h at room temperature.
Puri®cation of ABP140 from yeast cells
All manipulations were carried out at 0 ± 48C. Yeast cells of a strain BJ5457 (30 g wet weight) were suspended in 60 ml of Buer A (25 mM Tris/HCl at pH 7.5, 5 mM EGTA, 0.5 mM EDTA, 1 mM DTT, 0.3 M sorbitol, 10 mg/ml of leupeptin, 20 mg/ml of aprotinin, 10 mM (p-amidino-phenyl) methanesulfonyl¯uoride and 1 mg/ml of pepstatin A). The cell suspension was homogenized with 30 ml of glass beads (0.45 mm diameter). The homogenate was centrifuged at 1700 g for 10 min. The resulting supernatant was further centrifuged at 100 000 g for 1 h. The supernatant (60 ml, 700 mg of protein) was used as the cytosol fraction and stored at 7808C until use (Masuda et al., 1994) . The pellet was resuspended with the same volume of Buer A and used as the crude membrane fraction (60 ml, 600 mg of protein). The cytosol fraction of the yeast cells was pooled to 300 ml. One-tenth of the cytosol fraction (30 ml, 350 mg of protein) was applied to a Mono S HR16/10 column (1.6610 cm, Pharmacia) equilibrated with Buer B (20 mM HEPES/NaOH at pH 7.4, 1 mM DTT and 10 mM (pamidino-phenyl)methanesulfonyl¯uoride). The column was washed with 100 ml of Buer B and elution was performed with a 200 ml-linear gradient of NaCl (0 ± 500 mM) in Buer B. Fractions of 10 ml each were collected. ABP140 appeared in Fractions 11 ± 14 (see Figure 2A) . The same procedures were repeated ten times and the active fractions of the ten column chromatographies were pooled. A half of these samples (200 ml, 40 mg of protein) was applied to a hydroxyapatite column (1.0610 cm, Koken) equilibrated with Buer C (20 mM potassium phosphate at pH 7.5 and 1 mM DTT). Elution was performed with a 120 ml-linear gradient of potassium phosphate (20 ± 500 mM) in Buer C. Fractions of 4.0 ml each were collected. ABP140 appeared in Fractions 10 ± 13 (see Figure 2B ). The same procedures were repeated twice and the active fractions of the two column chromatographies were pooled. One-sixth of these samples (5.2 ml, 3.9 mg of protein) was applied to a TSKgel phenyl-5PW RP column (0.7567.5 cm, Tosoh) equilibrated with 0.05% tri¯uoroacetic acid. Elution was performed with a 100 ml-linear gradient of acetonitrile (0 ± 80%) in 0.05% tri¯uoroacetic acid. Fractions of 1.0 ml each were collected. ABP140 appeared in Fractions 42 ± 46 (see Figure 2C ). The same procedures were repeated six times and each peak fraction (Fraction 43) of the six column chromatographies (6.0 ml, 0.6 mg of protein) was combined and stored at 48C until use.
Peptide mapping of ABP140
The TSKgel phenyl-5PW RP sample of ABP140 (30 mg of protein) was subjected to SDS ± PAGE. The protein band corresponding to ABP140 was cut out from the gel and digested with lysyl endopeptidase, and the digested peptides were separated by TSKgel ODS-80Ts (0.46615 cm, Tosoh) reverse phase high-performance liquid column chromatography as described (Imazumi et al., 1994) . The amino acid sequences of the ®ve peptides were determined with a peptide sequencer (PSQ-1-gas phase sequencer, Shimazu; HP G1005A protein sequencing system, HP). To determine the N-terminal amino acid sequence, the phenyl-5PW RP sample of ABP140 (1.4 mg of protein) was subjected to SDS ± PAGE and transferred to a polyvinylidene di¯uoride membrane. The protein band was cut out from the membrane and directly subjected to the peptide sequencer.
Plasmid constructions
Standard molecular biological techniques were used to construct plasmids (Sambrook et al., 1989) . A 1.9 kilobase pairs (kbp) DNA fragment encoding the entire open reading frame of ABP140 with the BamHI and KpnI sites upstream of the methionine codon and the BamHI and PvuII sites downstream of the termination codon was isolated from the total yeast genome by polymerase chain reaction (PCR), which was performed using the 5' primer 5'-GCGCGGATCCGGTACCATGGGTGTCGCAGATT-TGATC-3' and 3' primer 5'-GCGCGGATCCCAGCTG-GGTACCTTATGATGAGAGAGGAGGTGG-3' corresponding to the N and C terminus, respectively. The 1.9 kbp BamHI ± PvuII PCR fragment containing ABP140 was cloned into the BamHI-PvuII site of URA3-bearing multicopy vector pKT10-GAL-HA, which had GAL1 promoter and two copies of the HA epitope, to construct pKT10-GAL-HA-ABP140. The 1.9 kbp BamHI ± BamHI PCR fragment containing ABP140 was cloned into the BamHI site of pTrcHis vector. A plasmid pTrcHisabp140::LEU2 was made from pTrcHis-ABP140 by insertion of the 2.2 kbp SalI ± XhoI LEU2 fragment into the SalI site of ABP140. The 1.9 kbp BamHI ± PvuII PCR fragment of ABP140 was cloned into the BamHI ± SmaI site of URA3-bearing single copy vector pRS316-GAL-HA, which had GAL1 promoter and two copies of the HA epitope, to construct pRS316-GAL-HA-ABP140.
Expression and puri®cation of recombinant ABP140
The plasmid pKT10-GAL-HA-ABP140 was introduced into a yeast strain BJ5457 by the lithium acetate method (Gietz et al., 1992) . The transformants were screened for growth on SD-ura plate medium (2% glucose, 0.7% yeast nitrogen base without amino acids, and required amino acids and bases) and cultured in SGATA medium (3% galactose, 0.2% sucrose, 0.5% casamino acids, 0.7% yeast nitrogen base without amino acids, 0.025% L-tryptophan, and 0.025% adenine sulfate dehydrate) with continuous agitation at 308C. The cells were harvested and the cytosol fraction of the cells was prepared as described above.
To purify recombinant HA-tagged ABP140, the cytosol fraction (10 ml, 200 mg of protein) was applied to a Mono S HR10/10 column (1.0610 cm) equilibrated with Buer B. The column was washed with 50 ml of Buer B, and elution was performed with an 80 ml-linear gradient of NaCl (0 ± 500 mM) in Buer B. Fractions of 4.0 ml each were collected. ABP140 appeared in Fractions 11 ± 14. The active fractions (16 ml, 4.8 mg of protein) were applied to a hydroxyapatite column (0.565 cm) equilibrated with Buer C. Elution was performed with a 15 ml-linear gradient of potassium phosphate (20 ± 500 mM) in Buer C. Fractions of 0.5 ml each were collected. ABP140 appeared in Fractions 13 ± 16. The active fractions (2.0 ml, 2.0 mg of protein) were applied to a Superdex 200 HR10/30 column (1.0630 cm, Pharmacia) equilibrated with Buer D (20 mM HEPES/ NaOH at pH 7.4, 1 mM DTT and 250 mM KCl). Elution was performed with Buer D. Fractions of 0.5 ml each were collected. ABP140 appeared in Fractions 23 ± 26. The active fractions (2 ml, 0.5 mg of protein) were collected and stored at 48C until use.
Assay for sedimentation of F-actin G-actin was polymerized by incubation for 30 min at room temperature in a polymerization buer (20 mM imidazole/ HCl at pH 7.0, 2 mM MgCl 2 , 1 mM ATP and 90 mM KCl). Puri®ed recombinant HA-tagged ABP140 (300 nM) was mixed with F-actin (0.5 mg/ml) and incubated for 45 min at 258C in 100 ml of a solution containing 20 mM HEPES/ NaOH at pH 7.4, 10 mM imidazole/HCl at pH 7.4, 120 mM KCl, 2 mM MgCl 2 , and 1 mM ATP. The mixture was then centrifuged at 130 000 g for 20 min at 48C. The supernatant was removed and the precipitate was carefully washed with the same solution. The supernatant and precipitate were solubilized and subjected to SDS ± PAGE, followed by protein staining with Coomassie brilliant blue.
Low shear viscometry
Low shear viscosity was measured as described Kato et al., 1996) . Brie¯y, recombinant HA-tagged ABP140 (5 ± 40 nM) was mixed with G-actin (0.3 mg/ml) in 100 ml of a solution containing 20 mM HEPES/NaOH at pH 7.4, 140 mM KCl, 0.1 mM ATP, and 1.0 mM EGTA, and the mixture was sucked into a 0.1 ml micropipette. After the incubation at 258C, the time for a stainless steel ball to fall a ®xed distance in the pipette was measured.
Electron microscopy of F-actin
Recombinant HA-tagged ABP140 (150 nM) was mixed with F-actin (0.15 mg/ml) in 100 ml of a solution containing 20 mM HEPES/NaOH at pH 7.4, 3 mM imidazole/HCl at pH 7.4, 90 mM KCl, 2 mM MgCl 2 , and 1 mM ATP, and the mixture was incubated for 45 min at 258C. The sample was negatively stained with 2% uranyl acetate and viewed with a transmission electron microscope (model H-7100, Hitachi) .
Assay for pyrene-conjugated actin assembly
Pyrene-conjugated actin polymerization was measured as described . Brie¯y, G-actin (0.125 mg/ml, containing 20% pyrene-conjugated actin) was mixed with recombinant HA-tagged ABP140 (200 nM) or gelsolin (200 nM) in 100 ml of a solution containing 5 mM HEPES/NaOH at pH 7.4, 1.3 mM Tris/ HCl, 0.25 mM DTT, 0.13 mM CaCl 2 , 150 mM KCl and 2 mM MgCl 2 . The actin polymerization reaction was initiated by the addition of KCl and MgCl 2 , and the mixture was incubated in a cuvette at 258C. Pyrenē uorescence was monitored continuously by a spectrouorimeter (excitation 365 nm, emission 386 nm).
Disruption and localization of ABP140
ABP140 was disrupted as follows. The pTrcHisabp140::LEU2 was cut with BamHI and the digested DNA was introduced into a wild type haploid strain OHNY1 (MATa ura3 leu2 trp1 his3 ade2). The genomic DNA was isolated from each transformant and the proper disruption of ABP140 was veri®ed by PCR. The pRS316-GAL-HA-ABP140 was introduced into these ABP140-null mutant cells, and cultured in SG-ura medium (3% galactose, 0.2% sucrose, 0.7% yeast nitrogen base without amino acids, and required amino acids and bases) at 248C. To visualize the localization of ABP140, the ABP140-null mutant cells expressing HA-tagged ABP140 were processed for indirect immuno¯uorescence microscopy by the method as described . Brie¯y, the cells were ®xed with 4% formaldehyde for 2 h at 248C, and the anti-HA mAb (25 mg/ml) was used as a primary antibody and the FITC-conjugated goat anti-mouse IgG (10 mM/ml, Cappel Labo.) was used as a secondary antibody. F-Actin was stained with rhodamine-phalloidin (0.5 mM, Molecular Probes Inc.) as described . Stained cells were observed and photographed using a Zeiss Axiophot microscope (Carl Zeiss).
Other procedures SDS ± PAGE (8% polyacrylamide gel) was performed as described (Laemmli, 1970) . Protein concentrations were determined with bovine serum albumin as a reference protein (Bradford, 1976) .
